Article
PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation.
The Journal of clinical investigation - 2 Jan 2024
Wang Jian, Chen Yuke, Li Shiwei, Liu Wanchang, Zhou Xiao Albert, Luo Yefei, Xu Zhanzhan, Xiong Yundong, Cheng Kaiqi, Ruan Mingjian, Yu Wei, Li Xiaoman, Wang Weibin, Wang Jiadong
Abstract excerpt
Mutations in the BRCA2 tumor suppressor gene have been associated with an increased risk of developing prostate cancer. One of the paradoxes concerning BRCA2 is the fact that its inactivation affects genetic stability and is deleterious for cellular and organismal survival, while BRCA2-mutated cancer cells adapt to this detriment and malignantly proliferate. Therapeutic strategies for tumors arising from BRCA2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
